Please input keywords
top
YH002
2020.06.30

Drug : YH002(OX40)

Progress : Phase I clinical trial

Indication : Solid tumor


Country/Region : Australia

Study Title : A First-in-Human (FIH), Multicenter, Open-Label, Phase 1 Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of YH002 in Subjects with Advanced Solid Malignancies

Link to Trial :  https://clinicaltrials.gov/ct2/show/NCT04353102